Y. Sahin et al., LACK OF RELATIONSHIP BETWEEN 17-HYDROXYPROGESTERONE RESPONSE TO BUSERELIN TESTING AND HYPERINSULINEMIA IN POLYCYSTIC-OVARY-SYNDROME, European journal of endocrinology, 136(4), 1997, pp. 410-415
Objective: To determine whether hyperinsulinism affects cytochrome P45
0c17 alpha activity by investigating the correlation between 17-hydrox
yprogesterone (17-OHP) hyper-responsiveness to the gonadotropin-releas
ing hormone (GnRH) agonist, buserelin, and the insulin response to ora
l glucose in polycystic ovary syndrome (PCOS). Design: Ultrasound, cli
nical and hormonal parameters were used to define PCOS in this prospec
tive clinical study. We investigated the correlation between the 17-OH
P response to buserelin testing and the insulin response to oral gluco
se in PCOS, Methods: Twenty-eight women with PCOS and eighteen normal
women were included in the study. 17-OHP response to buserelin, and in
sulin and C-peptide responses to oral glucose were measured, Results:
Twenty-five women with PCOS had an increased 17-OHP response. The PCOS
patients showed significantly higher mean post-glucose load insulin a
nd C-peptide levels than controls (P<0.05). No significant correlation
s were found between basal 17-OHP and fasting insulin or fasting C-pep
tide, between peak 17-OHP and fasting insulin, peak insulin or peak C-
peptide, between 17-OHP area under the curve (AUG) and insulin AUC or
C-peptide AUC, and between percent increment in 17-OHP and insulin AUC
or C-peptide AUC (P>0.05), Conclusions: Lack of a relationship betwee
n the 17-OHP response to the GnRH agonist buserelin and hyperinsulinis
m suggests that hyperinsulinism mag not play a role in the dysregulati
on of the cytochrome P450c17 alpha enzyme seen in PCOS.